INTRODUCTION
. GSH and the enzymes involved in its synthesis decline with age (Suh et al., 2004) . However, information concerning changes in the levels of sulfur amino acids and their metabolites as well as activities of enzymes involved in sulfur amino acid metabolism in mice is limited, particularly over the entire life span.
In mammals, the liver plays a central role in sulfur amino acid metabolism, where almost 50% of methionine metabolism and up to 85% of methylation reactions occur (Stipanuk, 2004) . The first step in methionine metabolism is the formation of S-adenosylmethionine (SAM), which is catalyzed by methionine adenosyltransferase I/III (MAT I/III). SAM serves as a methyl donor for biological methylation reactions, and the coproduct of transmethylation, S-adenosylhomocysteine (SAH), is hydrolyzed by SAH hydrolase (SAHH) to yield homocysteine that is either competitively remethylated to methionine or condensed into cystathionine with serine (Kim and Kim, 2005) . Two enzymes independently mediate remethylation: methionine synthase (MS) and betaine-homocysteine methyltransferase (BHMT). MS is a cobalamin-dependent enzyme that requires methylenetetrahydrofolate reductase (MTHFR) as a folate cycle enzyme to generate the methyl donor, 5-methyltetrahydrofolate, for homocysteine remethylation by MS. BHMT uses betaine as a methyl donor, and is mainly expressed in the liver, although BHMT activity is also observed in the kidney. Transsulfuration of homocysteine to cysteine via cystathionine is mediated by the consecutive actions of cystathionine β-synthase (CβS) and cystathionine γ-lyase. Homocysteine distribution between the two competitive reactions provides a major regulatory locus for the hepatic metabolism of sulfur amino acids (Finkelstein and Martin, 2000) . Cysteine is metabolized in the liver to yield either taurine, inorganic sulfate, or GSH. Cysteine dioxygenase (CDO) catalyzes the oxidation of this amino acid to cysteine sulfonate, which is converted mainly to hypotaurine by cysteine sulfinate decarboxylase (CDC) activity. Hypotaurine is non-enzymatically transformed into the end product taurine. GSH synthesis is consecutively mediated by γ-glutamylcysteine ligase (GCL) and GSH synthetase (Stipanuk, 1986) .
Changes in sulfur amino acid metabolism can be associated with an increased risk of a number of common late-life diseases, which raises the possibility that metabolism of sulfur amino acid may change with age. The aim of the present study was to investigate the effect of aging on the hepatic metabolism of sulfur-containing amino acids in 2-month-old (young), 6-month-old (adult), 18-month-old (middle-aged), and 30-month-old (aged) male mice. For this purpose, we compared sulfur amino acid metabolite profiles (i.e., methionine to taurine or GSH) in plasma and liver in mice of four ages. Moreover, we examined the hepatic levels and activities of enzymes involved in sulfur amino acid metabolism to determine whether differences in sulfur amino acid metabolic profiles reflected changes in the activities of their metabolizing enzymes.
MATERIALS AND METHODS

Reagents
Chemicals including amino acid standards, DL-homocysteine, L-cysteine, L-methionine, GSH, GSH disulfide (GSSG), SAH, SAM, taurine, hypotaurine, L-serine, cystathionine, betaine hydrochloride, adenosine, homocysteine thiolactone, N-(2-mercaptopropionyl)-glycine (MPG), NAD + , ATP, MgCl2, ethylenediaminetetraacetic acid (EDTA), pyridoxal-5-phosphate, 5-methyl-tetrahydrofolate, hydroxocobalamin, 1-heptanesulfonic acid, trichloroacetic acid (TCA), tris-(2-carboxyethyl)-phosphine hydrochloride (TCEP), ammonium-7-fluorobenzo-2-oxa-1,3-diazole-4-sulfonic acid (SBD-F), 2-mercaptoethanol, dithiothreitol (DTT), chloroform, potassium chloride, hydrochloric acid, sodium acetate, methanol, acetonitrile, tris(hydroxymethyl)aminomethane, ferrous ammonium sulfate, 5,5-dithiobis-2-nitrobenzoic acid (DTNB), hydroxylamine, 2-vinyl pyridine, sodium hydroxide, sodium carbonate, boric acid, bovine serum albumin (BSA), and sodium dodecyl sulfate (SDS) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Perchloric acid (PCA), sodium dihydrogen phosphate and disodium hydrogen phosphate were purchased from Junsei Chemical (Tokyo, Japan). Antibodies against MATI/III and MTHFR were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA) and the anti-SAHH, anti-MS, anti-CDO and anti-β-actin antibodies were purchased from Abcam (Cambridge, UK). The anti-BHMT antibody was purchased from Everest Biotech (Oxfordshire, UK). The anti-GCL catalytic subunit (GCLC) and anti-GCL modifier subunit (GCLM) antibodies were purchased from NeoMarker Inc. (Fremont, CA). The anti-CβS antibody was kindly provided by Dr. Matherly (Wayne State University School of Medicine, Detroit, MI, USA). Horseradish peroxidase-conjugated goat anti-rabbit and rabbit anti-goat antibodies were purchased from BioRad Laboratories (Hercules, CA, USA). Enhanced chemiluminescence detection reagent solutions were purchased from Thermo Scientific (Rockford, IL, USA). All chemicals and solvents used in this study were reagent grade or higher.
Animal experiments
This study used male C57BL/6 mice, and all animals were maintained at the Korea Research Institute of Bioscience and Biotechnology (Ochang, Korea). Mice aged 2-, 6-, 18-, or 30-months-old were classified as young, adult, middle-aged, and aged, respectively (Yang et al., 2013) , and each group consisted of five mice. The mice were housed in 22 ± 2°C and 50 ± 5% humidity controlled rooms with a 12-h light/dark cycle for at least 1 week prior to experimentation. Food and tap water were provided ad libitum. Mice were fed a 2018S Teklad global 18% protein rodent diet that contained the following 
Preparation of plasma and hepatic samples
Blood samples were obtained by heart puncture immediately after euthanasia from 9 to 10 am to minimize variations due to the circadian cycle. The standard protocol entailed euthanizing the mice by CO2 inhalation followed by maximal collection (approximately 1 mL) by cardiocentesis with a 1-mL syringe and a 25-gauge, 5/8-in. tuberculin needle. Plasma was obtained by centrifugation of the blood at 10,000×g for 15 min at 4°C. The plasma was stored at -70°C until analysis. The liver was removed rapidly and homogenized in a three-fold volume of ice-cold buffer consisting of 0.154 M KCl, 50 mM Tris-HCl, and 1 mM EDTA (pH 7.4). All subsequent steps were performed at 0-4°C. The liver homogenates were deproteinized in a three-fold volume of ice-cold methanol to measure methionine, hypotaurine, and taurine, or in an equal volume of 10% PCA to measure SAM, SAH, homocysteine, cysteine, GSH, GSSG, putrescine, spermidine, and spermine. After centrifugation at 10,000×g for 20 min, the supernatant fraction was collected and stored at -70°C.
For enzyme assay and immunoblot analysis, the liver homogenates were centrifuged at 10,000×g for 20 min. The supernatant was further centrifuged at 104,000×g for 65 min. The supernatant fraction was collected and refrigerated in -70°C (cytosol samples). Total protein concentration was measured using a bicinchoninic acid protein assay kit (Thermo Scientific).
Determination of sulfur amino acid content and their metabolites in plasma and tissues
The amount of methionine, hepatic SAM and SAH, total plasma and liver homocysteine, GSH, cysteine, hypotaurine, taurine, polyamines were determined according to our previous methods (Kwak et al., 2015) .
Immunoblot analyses
The expression of β-actin, MAT I/III, SAHH, BHMT, MS, MTHFR, CβS, CDO, GCLC and GCLM, the cytosol samples were determined according to our previous methods (Kwak et al., 2015) . The antibodies were diluted with PBS-T containing 3-5% BSA: β-actin (1:2,000), MATI/III (1:3,000), SAHH (1:500), BHMT (1:5,000), MS (1:200), MTHFR (1:200), CβS (1:2,000), CDO (1:1,000), GCLC (1:3,000) and GCLM (1:2,000).
Enzyme assays
Activities of MAT, SAHH, BHMT, MS, CβS, CDO and GCL were determined according to our previous methods (Kim et al., 2003; Kwak et al., 2015) .
Statistical analyses
Differences between groups were determined using analysis of variance followed by the Newman-Keuls multiple range test (p<0.05). All data are presented as mean ± standard deviation for five samples. Linear regression was calculated using GraphPad Prism, ver. 4.0 software (GraphPad Software Inc., San Diego, CA, USA).
RESULTS
Body weight and liver weight
Body weight increased with age, peaking in 18-monthold mice, and subsequently decreasing in 30-month-old mice (Fig. 1A) . Body weight of 2-month-old mice was significantly different from all other groups, and body weight of 30-month-old mice decreased significantly, relative to that of 18-month-old mice. Liver weight per body weight was the lowest in 18-month-old mice (Fig. 1B) . The relative liver weight of 18-month-old-mice was significantly different from that of 2-month-old mice. These results are consistent with previous findings (Anisimov et al., 2010) .
Sulfur amino acid concentrations in plasma
Cysteine, homocysteine, GSH, and methionine concentrations were determined in plasma collected from mice at 2, 6, 18, or 30 months of age ( Table 1 ). There were no significant differences in plasma total cysteine or homocysteine levels in mice. Plasma total GSH levels decreased with age, and thus the GSH levels in 30-month-old mice decreased to 45% relative to that in 2-month-old mice. There were no significant differences in plasma methionine levels in mice.
Sulfur amino acid concentrations in liver
Hepatic concentrations of sulfur amino acids and their metabolites were monitored with increasing age in mice (Table  2) . Hepatic methionine and cysteine levels were increased in 30-month-old mice relative to 2-, 6-, and 18-month-old mice. In contrast, hepatic total homocysteine levels were decreased in 6-, 18-, and 30-month-old mice relative to those in 2-monthold mice. There were no significant differences in hepatic total GSH, reduced GSH, GSSG levels or GSH/GSSG ratio. He- patic SAM and SAH levels decreased with age, and thus the SAM/SAH ratio, which serves as an index of transmethylation potential, did not significantly change with age. Hepatic hypotaurine levels in 6-, 18-, or 30-month-old mice were more than twofold those observed in 2-month-old mice, and hepatic taurine levels in 6-, 18-and 30-month-old mice were approximately 52, 165, and 143%, respectively, relative to those in 2-month-old mice, despite the lack of significant differences. SAM is a source of the propylamine group for synthesis of spermidine and spermine, following its decarboxylation by SAM decarboxylase (Grillo, 1985) . Hepatic spermidine and spermine levels were determined to test whether polyamine synthesis may be associated with the decrease in hepatic SAM levels. No differences in hepatic spermidine or spermine levels were detected in mice.
Immunoblot analysis of sulfur amino acid metabolizing enzymes
The relative level of hepatic enzymes involved in sulfur amino acid metabolism was determined using immunoblot analysis with specific antibodies in mice aged 2, 6, 18, and 30 months (Fig. 2) . MAT I/III and CβS were increased in 18-and 30-month-old mice relative to 2-and 6-month-old mice ( Fig. 2A, 2E) . SAHH was higher in 6-month-old mice than in 2-month-old mice (Fig. 2B) , while BHMT was minimal in 6-month-old mice (Fig. 2C) . MS was increased in 30-monthold mice relative to 2-and 18-month-old mice (Fig. 2D) . GCLC and GCLM levels were lower in 30-month-old mice than in 6-month-old mice level (Fig. 2F, 2G ). CDO levels were markedly lower in 2-month-old mice (Fig. 2H) . No age-related differences were observed in hepatic β-actin levels used as a loading control (Fig. 2I) .
Activities of sulfur amino acid metabolizing enzymes
The activities of hepatic enzymes involved in sulfur amino acid metabolism are regulated by post-translational modification and allosteric regulation . Thus, the activities of MAT, SAHH, MS, BHMT, CβS, GCL and CDO were measured using a HPLC system equipped with a fluorescence detector, an ultraviolet detector, or a tandem mass spectrometry (MS/MS) system (Fig. 3) . MAT, MS, CβS and GCL activity patterns were similar to their immunoblot assay results (Fig. 3A, 3D, 3E, 3F ). SAHH activity was decreased in 30-month-old mice relative to 2-, 6-, and 18-month-old mice (Fig. 3B ). There were no significant differences in BHMT or CDO activity (Fig. 3C, 3G) .
DISCUSSION
The present study demonstrated sulfur amino acid metabolism changes with increasing age in mice. With the exception of plasma GSH and hepatic homocysteine, the levels of the other sulfur amino acids examined and their metabolites in plasma and liver did not differ significantly among 2-, 6-and 18-month-old mice. The plasma GSH level decreased with age, and the hepatic total homocysteine level was significantly higher in 2-month-old mice than in older mice. In contrast, we observed changes in hepatic methionine, cysteine, SAM and SAH in 30-month-old mice, suggesting that alterations in hepatic sulfur amino acid metabolism may occur in aged mice. Neither GSH nor taurine level was significantly different in liver, although hepatic taurine levels were 3.1-and 2.7-fold in 18-and 30-month-old mice, respectively, relative to 6-monthold mice.
There were no significant differences in plasma total cysteine or homocysteine levels with increasing age in mice, but plasma total GSH level decreased with age. Decrease in plasma GSH was observed in aged humans (Yang et al., 1995) , as well as in experimental animals, including monkeys (Paredes et al., 2014) and mice (Iciek et al., 2004) . In contrast, age-related changes in hepatic GSH levels are controversial. In 24-month-old Fisher 344 rats, hepatic GSH levels were decreased by GCL down-regulation (Liu and Choi, 2000) . Moreover, nuclear factor erythroid 2-related factor 2-mediated activation of antioxidant enzyme expression, including GCL, was reduced in rats greater than 24 months of age (Suh et al., 2004) . In contrast, hepatic GSH was similar among male rats at 4-5, 14-15, or 24-25 months of age (Rikans and Kosanke, 1984) . These results are supported by findings from 2-and 27-month-old Wistar rats (Barja de et al., 1990) and from 5-week-old to 30-month-old Fisher rats (Nakata et al., 1996) . In this study, hepatic total GSH, reduced GSH, GSSG and GSH/GSSG did not differ significantly among the groups. These results are consistent with previous findings using 3-, 12-, 24-, and 30-or 31-month-old C57BL/6 mice (Chen et al., 2000) , the same strain of mice used in this study. The reason for this discrepancy in the effect of aging on hepatic GSH levels remains unknown, but the rate of de novo GSH synthesis is controlled by cysteine availability as well as GCL activity. Elevated hepatic cysteine levels may be associated with the maintenance of hepatic GSH levels despite decreased GCL activity.
In the present study, GSH levels in plasma, but not liver, decreased with age. Plasma GSH levels are controlled by hepatic GSH efflux regulation and GSH utilization in extrahepatic tissues (Lu et al., 1990) . The hepatic efflux of GSH is the source of almost 85% of the GSH plasma concentration in the rat (Kaplowitz et al., 1985) . Plasma GSH is used as a continuous source of cysteine in extrahepatic tissues via the gamma-glutamyl cycle (Lu, 2013) . Thus, plasma GSH levels can be decreased by both or either of the following: an increase in extra-hepatic utilization of plasma GSH and/or a decrease in hepatic efflux of GSH into plasma. Interestingly, serum gamma-glutamyltranspeptidase activity increased with age in humans (Strømme et al., 2004) , suggesting that plasma GSH can be decreased by aging via a tissue-independent mechanism.
Cysteine and methionine increased in the livers of 30-month-old mice, compared with those in all other groups, but total homocysteine, SAH and SAM decreased, relative to those in 2-month-old mice. Decreased hepatic homocysteine and increased hepatic cysteine may be attributable, in part, to induction of CβS, which produces cysteine from homocys- teine via cystathionine, and inhibition of GCL, which utilizes cysteine to produce GSH via gamma-glutamylcysteine. Previous studies have shown a direct repressing effect of insulin on CβS in human and rat hepatocytes (Ratnam et al., 2002) , and upregulation of hepatic CβS in streptozotocin-induced diabetes (Jacobs et al., 1998) . These results warrant further investigation of the role of insulin production and/or insulin signaling on hepatic sulfur amino acid metabolism in aged animals. Despite the increase in methionine, a SAM precursor, and MAT I/III up-regulation, a SAM synthesizing enzyme, hepatic SAM levels were markedly decreased in 30-month-old mice. SAM serves as a methyl donor for methylation reactions and is a source for the propylamine group in polyamine synthesis. Hepatic concentrations of the polyamines including spermidine and spermine were not different among 2-, 6-, 18-and 30-month-old mice. Thus, the underlying mechanism for SAM regulation in 30-month-old mice remains to be determined. Hepatic sulfur amino acid metabolism plays a major role in the maintenance of methionine concentration. Hepatic SAM serves as a regulator of hepatic sulfur amino acid metabolism. SAM exerts feedback activation on MAT (Cabrero et al., 1987) . SAM is also an allosteric activator of CβS and an allosteric inhibitor of MTHFR (Brosnan and Brosnan, 2006) . Moreover, SAM inactivates BHMT in rat liver (Finkelstein and Martin, 1986 ) and down-regulates BHMT expression in HepG2 cells (Ou et al., 2007) . Elevated hepatic SAM can accelerate the consumption of excessive methionine to produce cysteine via increased homocysteine transsulfuration and decreased homocysteine remethylation. Thus, these previous findings in conjunction with the present results indicate that the regulation of hepatic sulfur amino acid metabolism is impaired in 30-month-old mice, although the mechanism underlying the decreased hepatic SAM level remains to be determined.
High methionine and cysteine concentrations can be quite toxic (Benevenga and Steele, 1984) . Excessive methionine leads to growth retardation and histopathological changes in the liver, kidney, and spleen (Harper et al., 1970) . In addition, mice fed methionine-rich diets had significant atheromatous pathology in the aortic arch, even with normal plasma homocysteine levels (Troen et al., 2003) . Moreover, hyperhomocysteinemia can be the result of high methionine diets up to 12-20 g/kg. In fact, animals with hyperhomocysteinemia induced by a high-methionine diet develop vascular diseases, neurological disorders, and aortic diseases (Dayal and Lentz, 2008) . The potent toxicity of excess cysteine was also demonstrated in humans as well as in experimental animals (Baker, 2006; Stipanuk et al., 2006) . Cysteine undergoes auto-oxidation in the presence of iron, resulting in reactive oxygen species, and consequently leads to oxidative damage (Iyamu et al., 2008) . Chronic excessive cysteine exposure is closely associated with an increased risk of a number of common diseases, including rheumatoid arthritis, Parkinson's disease, Alzheimer's disease, and increased risk of cardiovascular disease (Heafield et al., 1990; Mills et al., 2000) . Thus, excessive hepatic methionine and cysteine can lead to toxic reactions in aged mice, exhibiting impaired hepatic sulfur amino acid metabolism.
In conclusion, a simplified scheme of hepatic sulfur amino acid metabolism and changes in sulfur amino acids and their metabolites in 30-month-old mice is illustrated in Fig. 4 . The 30-month-old mice exhibited alterations in hepatic sulfur amino acid metabolism, such as elevated hepatic cysteine and methionine, and decreased SAM, SAH, and total homocysteine. Changes in liver homocysteine and cysteine may be attributable to up-regulation of CβS and down-regulation of GCL. Despite the increase in methionine and up-regulation of MAT I/III, hepatic SAM levels were markedly decreased in 30-month-old mice. Opposing changes between methionine and SAM in liver raise the possibility that the regulatory role of SAM in hepatic sulfur amino acid metabolism may be impaired in 30-month-old mice. These results provide a rationale for an increased life span in animals fed a methionine-restricted diet.
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